DESTINA is a biotechnology company that specializes in nucleic acid testing and diagnostic assay solutions. Established in Edinburgh in 2011, DESTINA was founded with the mission to transform the field of nucleic acid testing by commercializing a patented chemistry that enables the detection of nucleic acids with unparalleled precision. Their innovative technology offers a unique approach to RNA detection, addressing stability issues and streamlining laboratory workflows.

By leveraging circulating RNA as a biomarker, DESTINA aims to revolutionize research, drug development, and clinical diagnostics. Their ambition is to become a market leader and innovator in the field of molecular diagnostics, enabling earlier and more accurate disease detection for improved patient outcomes. With a highly experienced and multidisciplinary team, DESTINA is committed to innovation and collaboration.

Based in Edinburgh and Granada, their strategic locations provide access to scientific excellence and innovation in the life sciences. Join DESTINA on their journey to shape the future of molecular diagnostics